Ascendia Pharmaceuticals Inc.

11/19/2025 | Press release | Archived content

Ascendia Pharmaceutical Solutions Highlights Jim Huang’s Presentation at APV Mainz Seminar 2025

Ascendia Pharmaceutical Solutions announces that Jingjun "Jim" Huang, Ph.D., Founder and CEO, will present at the upcoming APV Mainz Seminar. The seminar will take place in Mainz, Germany, on Thursday, November 20th, 2025. Jim Huang's session is scheduled after lunch, providing an in-depth exploration of formulation development and rational process design strategies for sterile suspensions.

Process Design Strategy for Sterile Suspensions

Jim Huang will discuss the critical considerations in formulation development of sterile nano suspensions for long-acting injectables (LAI) and other nano dosage forms, emphasizing both top-down and bottom-up manufacturing approaches. The presentation will provide actionable insights for optimizing suspension characteristics, ensuring reproducibility, and maintaining regulatory compliance. Attendees will gain a clear understanding of formulation and process design parameters and practical implementation strategies through real-life case studies.

Hands-On Demonstration with Netzsch Equipment

During the session, Jim Huang will showcase the aseptic nano wet milling machine using a customized Netzsch machine, highlighting its role in particle size reduction and formulation consistency. The demonstration will allow participants to observe the practical application of advanced equipment in sterile suspension development. This session offers a rare opportunity to see equipment performance in real-time while connecting theory to practice.

Meet Ascendia Pharmaceutical Solutions at APV Mainz Seminar

Ascendia Pharmaceutical Solutions provides specialized contract development and manufacturing services for sterile suspensions and complex pharmaceutical nano-formulations. The company's expertise spans process design, formulation optimization, scale-up, and manufacturing support.

Engage with Jim Huang and Ascendia Pharmaceutical Solutions

Attendees are encouraged to meet with Jim Huang and the Ascendia Pharmaceutical Solutions team virtually at the APV Mainz Seminar. to discuss custom development strategies or attend Jim Huang's presentation to explore the latest innovations in sterile suspension manufacturing.

Contact Ascendia Pharmaceutical Solutions to secure a meeting at the APV Mainz Seminar or register for Jim Huang's session. Access expert guidance, observe advanced equipment, and gain insights that accelerate formulation and process development.

Ascendia Pharmaceuticals Inc. published this content on November 19, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on February 24, 2026 at 15:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]